The Effects of RBP4 and Vitamin D on the Proliferation and Migration of Vascular Smooth Muscle Cells via the JAK2/STAT3 Signaling Pathway

Table 3

Correlation among RBP4, 25(OH)D, and the other indicators in T2DM groups ().

	RBP4		25(OH)D
	LDL-c	0.401	≤0.001	-0.294	0.002
TG	0.456	≤0.001	-0.051	0.604
TC	0.616	≤0.001	-0.480	≤0.001
HDL-c	-0.733	≤0.001	0.435	≤0.001
HbA1C	0.162	0.078	-0.201	0.037
FPG	0.177	0.069	-0.273	0.004
FINS	0.655	≤0.001	-0.063	0.522
RBP4	—	—	-0.274	0.004
HOMA-IR	0.606	≤0.001	-0.200	0.039
25(OH)D	-0.274	0.004	—	—
ISI	-0.626	≤0.001	0.345	≤0.001
Weight	0.241	0.013	-0.471	≤0.001
MT	0.587	≤0.001	-0.052	0.592
LD	0.592	≤0.001	-0.348	≤0.001
JAK2	0.753	≤0.001	-0.374	≤0.001
STAT3	0.758	≤0.001	-0.238	0.014
cyclinD1	0.699	≤0.001	-0.365	≤0.001
Bcl-2	0.744	≤0.001	-0.220	0.023

LDL-c: low-density lipoprotein cholesterol; TG: triglycerides; TC: total cholesterol; HDL-c: high-density lipoprotein cholesterol; HbA1C: hemoglobin A1c; FPG: fasting plasma glucose; FINS: fasting insulin; RBP4: retinol binding protein 4; HOMA-IR: homeostasis model assessment of insulin resistance; ISI: insulin sensitivity index; MT: the media thickness of the artery; LD: lumen diameter; JAK2: Janus kinase 2; STAT3:signal transducer and activator of transcription 3; Bcl-2: B cell lymphoma-2.